Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2

A case who revealed the longest duration of viral shedding (67 days) in current reports, presented complicated characteristic on the relapse of COVID-19 due to the inconsistent performance of chest radiography and SARS-CoV-2-RNA detection after discharge. Lopinavir-interferon α2b boosted ribavirin f...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fang, Cai, Zhao-bin, Huang, Jin-song, Niu, Hai-ying, Yu, Wen-yan, Zhang, Yan, Yan, Ting-bo, Chen, Chen, Liu, Yuan, Xu, Ai-fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406422/
https://www.ncbi.nlm.nih.gov/pubmed/32807688
http://dx.doi.org/10.1016/j.jmii.2020.07.017
_version_ 1783567416450613248
author Liu, Fang
Cai, Zhao-bin
Huang, Jin-song
Niu, Hai-ying
Yu, Wen-yan
Zhang, Yan
Yan, Ting-bo
Chen, Chen
Liu, Yuan
Xu, Ai-fang
author_facet Liu, Fang
Cai, Zhao-bin
Huang, Jin-song
Niu, Hai-ying
Yu, Wen-yan
Zhang, Yan
Yan, Ting-bo
Chen, Chen
Liu, Yuan
Xu, Ai-fang
author_sort Liu, Fang
collection PubMed
description A case who revealed the longest duration of viral shedding (67 days) in current reports, presented complicated characteristic on the relapse of COVID-19 due to the inconsistent performance of chest radiography and SARS-CoV-2-RNA detection after discharge. Lopinavir-interferon α2b boosted ribavirin following with lopinavir boosted budesonide might be a potent treatment for viral clearance.
format Online
Article
Text
id pubmed-7406422
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
record_format MEDLINE/PubMed
spelling pubmed-74064222020-08-06 Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2 Liu, Fang Cai, Zhao-bin Huang, Jin-song Niu, Hai-ying Yu, Wen-yan Zhang, Yan Yan, Ting-bo Chen, Chen Liu, Yuan Xu, Ai-fang J Microbiol Immunol Infect Short Communication A case who revealed the longest duration of viral shedding (67 days) in current reports, presented complicated characteristic on the relapse of COVID-19 due to the inconsistent performance of chest radiography and SARS-CoV-2-RNA detection after discharge. Lopinavir-interferon α2b boosted ribavirin following with lopinavir boosted budesonide might be a potent treatment for viral clearance. Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2021-02 2020-08-06 /pmc/articles/PMC7406422/ /pubmed/32807688 http://dx.doi.org/10.1016/j.jmii.2020.07.017 Text en © 2020 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Liu, Fang
Cai, Zhao-bin
Huang, Jin-song
Niu, Hai-ying
Yu, Wen-yan
Zhang, Yan
Yan, Ting-bo
Chen, Chen
Liu, Yuan
Xu, Ai-fang
Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2
title Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2
title_full Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2
title_fullStr Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2
title_full_unstemmed Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2
title_short Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2
title_sort repeated covid-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with sars-cov-2
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406422/
https://www.ncbi.nlm.nih.gov/pubmed/32807688
http://dx.doi.org/10.1016/j.jmii.2020.07.017
work_keys_str_mv AT liufang repeatedcovid19relapseduringpostdischargesurveillancewithviralsheddinglastingfor67daysinarecoveredpatientinfectedwithsarscov2
AT caizhaobin repeatedcovid19relapseduringpostdischargesurveillancewithviralsheddinglastingfor67daysinarecoveredpatientinfectedwithsarscov2
AT huangjinsong repeatedcovid19relapseduringpostdischargesurveillancewithviralsheddinglastingfor67daysinarecoveredpatientinfectedwithsarscov2
AT niuhaiying repeatedcovid19relapseduringpostdischargesurveillancewithviralsheddinglastingfor67daysinarecoveredpatientinfectedwithsarscov2
AT yuwenyan repeatedcovid19relapseduringpostdischargesurveillancewithviralsheddinglastingfor67daysinarecoveredpatientinfectedwithsarscov2
AT zhangyan repeatedcovid19relapseduringpostdischargesurveillancewithviralsheddinglastingfor67daysinarecoveredpatientinfectedwithsarscov2
AT yantingbo repeatedcovid19relapseduringpostdischargesurveillancewithviralsheddinglastingfor67daysinarecoveredpatientinfectedwithsarscov2
AT chenchen repeatedcovid19relapseduringpostdischargesurveillancewithviralsheddinglastingfor67daysinarecoveredpatientinfectedwithsarscov2
AT liuyuan repeatedcovid19relapseduringpostdischargesurveillancewithviralsheddinglastingfor67daysinarecoveredpatientinfectedwithsarscov2
AT xuaifang repeatedcovid19relapseduringpostdischargesurveillancewithviralsheddinglastingfor67daysinarecoveredpatientinfectedwithsarscov2

Ejemplares similares